Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'.
Martora F, Fabbrocini G, Marasca C, Battista T, Megna M. Martora F, et al. Among authors: battista t. Clin Exp Dermatol. 2023 Jun 5;48(6):701-703. doi: 10.1093/ced/llad082. Clin Exp Dermatol. 2023. PMID: 36883596 No abstract available.
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
Martora F, Picone V, Battista T, Fabbrocini G, Marasca C. Martora F, et al. Among authors: battista t. Dermatol Ther. 2022 Aug;35(8):e15602. doi: 10.1111/dth.15602. Epub 2022 Jun 13. Dermatol Ther. 2022. PMID: 35622446 Free PMC article. No abstract available.
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'.
Martora F, Marasca C, Battista T, Fabbrocini G, Ruggiero A. Martora F, et al. Among authors: battista t. Clin Exp Dermatol. 2022 Nov;47(11):2026-2028. doi: 10.1111/ced.15306. Epub 2022 Aug 4. Clin Exp Dermatol. 2022. PMID: 35727206 Free PMC article. No abstract available.
Dupilumab for the treatment of adult atopic dermatitis in special populations.
Patruno C, Potestio L, Scalvenzi M, Battista T, Raia F, Picone V, Fabbrocini G, Napolitano M. Patruno C, et al. Among authors: battista t. J Dermatolog Treat. 2022 Nov;33(7):3028-3033. doi: 10.1080/09546634.2022.2102121. Epub 2022 Jul 19. J Dermatolog Treat. 2022. PMID: 35829641
107 results